Citadel Advisors’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $18.1M | Buy |
888,515
+630,133
| +244% | +$12.9M | ﹤0.01% | 1018 |
|
|
2025
Q1 | $5.17M | Sell |
258,382
-576,130
| -69% | -$11.5M | ﹤0.01% | 1727 |
|
|
2024
Q4 | $22.2M | Buy |
834,512
+201,496
| +32% | +$5.37M | ﹤0.01% | 889 |
|
|
2024
Q3 | $18.1M | Sell |
633,016
-60,369
| -9% | -$1.72M | ﹤0.01% | 906 |
|
|
2024
Q2 | $15.1M | Buy |
693,385
+37,619
| +6% | +$819K | ﹤0.01% | 1010 |
|
|
2024
Q1 | $14.5M | Buy |
655,766
+327,017
| +99% | +$7.24M | ﹤0.01% | 1058 |
|
|
2023
Q4 | $7.09M | Sell |
328,749
-189,309
| -37% | -$4.09M | ﹤0.01% | 1429 |
|
|
2023
Q3 | $8.75M | Buy |
518,058
+461,775
| +820% | +$7.8M | ﹤0.01% | 1243 |
|
|
2023
Q2 | $772K | Sell |
56,283
-604,673
| -91% | -$8.3M | ﹤0.01% | 3228 |
|
|
2023
Q1 | $15M | Buy |
660,956
+109,641
| +20% | +$2.49M | ﹤0.01% | 1027 |
|
|
2022
Q4 | $13M | Sell |
551,315
-181,340
| -25% | -$4.27M | ﹤0.01% | 1121 |
|
|
2022
Q3 | $19.1M | Buy |
732,655
+102,059
| +16% | +$2.66M | ﹤0.01% | 851 |
|
|
2022
Q2 | $13.8M | Buy |
630,596
+443,589
| +237% | +$9.74M | ﹤0.01% | 1063 |
|
|
2022
Q1 | $8.39M | Buy |
187,007
+89,121
| +91% | +$4M | ﹤0.01% | 1571 |
|
|
2021
Q4 | $4.2M | Sell |
97,886
-132,553
| -58% | -$5.68M | ﹤0.01% | 2275 |
|
|
2021
Q3 | $15.3M | Buy |
230,439
+170,434
| +284% | +$11.3M | ﹤0.01% | 1099 |
|
|
2021
Q2 | $4.4M | Sell |
60,005
-87
| -0.1% | -$6.38K | ﹤0.01% | 2304 |
|
|
2021
Q1 | $4.11M | Buy |
60,092
+50,103
| +502% | +$3.43M | ﹤0.01% | 2332 |
|
|
2020
Q4 | $670K | Sell |
9,989
-49,807
| -83% | -$3.34M | ﹤0.01% | 3609 |
|
|
2020
Q3 | $3.08M | Sell |
59,796
-1,606
| -3% | -$82.6K | ﹤0.01% | 1902 |
|
|
2020
Q2 | $2.32M | Buy |
+61,402
| New | +$2.32M | ﹤0.01% | 2118 |
|
|
2020
Q1 | – | Sell |
-8,900
| Closed | -$305K | – | 4896 |
|
|
2019
Q4 | $305K | Sell |
8,900
-21,775
| -71% | -$746K | ﹤0.01% | 3859 |
|
|
2019
Q3 | $555K | Buy |
+30,675
| New | +$555K | ﹤0.01% | 3401 |
|